Centocor Ortho Biotech seeks expanded approval for Simponi
HORSHAM, Pa. The biotech division of Johnson & Johnson is hoping to expand the use of a treatment for autoimmune disorders.
Centocor Ortho Biotech said it had filed an application with the Food and Drug Administration to get approval for Simponi (golimumab) to stop the progression of structural damage, induce major clinical response, maintain reductions in signs and symptoms, and improve physical function in the treatment of rheumatoid arthritis.
The FDA approved Simponi in April 2009 as a treatment for various forms of arthritis. When used to treat RA, it is combined with the drug methotrexate.
NRF responds to Chinese currency legislation
WASHINGTON Another group representing retailers has joined those opposed to legislation designed to pressure China to revalue its currency.
Following last week’s statement of opposition by the Retail Industry Leaders Association, the National Retail Federation is urging the House to reject H.R. 2378, the Currency Reform for Fair Trade Act, a bill that would require the Department of Commerce to determine whether a country’s currency is undervalued and constitutes an illegal export subsidy when considering cases of countervailing duties. The organization said the bill may violate certain World Trade Organization policies that determine what kinds of government financial contributions can be considered prohibited export subsidies and that it could set off retaliatory measures against U.S. exports by the Chinese.
Many members of Congress lately have stepped up criticism of China’s policy of pegging its currency, the renminbi yuan, to the U.S. dollar, saying that it constitutes currency manipulation that undercuts U.S. manufacturers.
“While we agree that the Chinese currency needs to move toward a market-determined exchange rate, H.R. 2378 would be ineffective in addressing the currency issue and would create significant costs for U.S. companies and workers in retail and other industries,” NRF SVP government relations Steve Pfister said. “This bill cannot provide effective leverage over China to resolve the currency issue or have any positive impact on either the trade deficit or U.S. jobs.”
Clorox gets new look
OAKLAND, Calif. Clorox unveiled its new corporate logo this week, marking the company’s most dramatic logo overhaul since 1957.
The nearly 100-year-old company said that the new logo reflects its focus on eco-friendly products and the strengthening of its brand portfolio.
"Our new logo better communicates what The Clorox Co. stands for today," said Clorox chairman and CEO Don Knauss. "We’ve kept visual elements that reflect our heritage, but we emphasized our forward-thinking mindset and objective to achieve strong growth, drive innovation and focus on sustainability."